Genomic Biobanking, Precision Diagnostics, and Real-World Evidence Platforms Reinforcing UK Clinical Trials Market Research Excellence
The UK Clinical Trials Market continues to strengthen as genomic biobanking and real-world evidence platforms support research-driven trial designs. Public initiatives promoting open-access genomic libraries help developers target rare disease populations more effectively. Advanced diagnostics further enhance trial precision by enabling treatment response prediction at a molecular level. These...
0 التعليقات 0 المشاركات 23 مشاهدة 0 معاينة